“You can't just have all or none treatments. You've got to have a middle ground for people who are going to look for that,” says John R. Valvo, MD.
In this video, John R. Valvo, MD, discusses an example of a potential candidate for high-intensity focused ultrasound treatment. Valvo is Director of Robotics at Rochester Regional Health in Rochester, New York, a clinical associate professor and Chief of Urology for Via Health in Rochester, and Executive Director of the Polissini Center for Robotic and Minimally Invasive Surgery at Rochester General Hospital.
Phase 1B trial to evaluate relugolix and enzalutamide in high-risk prostate cancer
July 24th 2024"Going forward after this study, we hope to be able to expand and potentially look at patients undergoing either surgery or radiation therapy, and really try to determine the potential benefit," says Kelly L. Stratton, MD, FACS.